Tizanidine Tablet
Product Images NDC 50090-6757

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 50090-6757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Fig1)

A pharmacokinetic graph showing plasma Tizanidine concentration (ng/mL) over time (hours) after dosing. The chart compares the concentration profiles of 2 x 4 mg Tizanidine tablets and capsules taken with and without food, illustrating differences in absorption and plasma levels up to 24 hours post-dose.*

FDA Label Image

Fig2 (Fig2)

A line graph depicting improvement in Ashworth score over time (hours post-dose) for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The y-axis measures improvement in Ashworth score, with both tizanidine doses showing greater improvement compared to placebo, peaking around 2 hours post-dose and declining thereafter.*

FDA Label Image

Fig3 (Fig3)

A line chart comparing the improvement in Ashworth Score between Tizanidine (mean dose 28.8 mg) and placebo over three study points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The chart shows greater improvement with Tizanidine compared to placebo at all points.*

FDA Label Image

Label Image (Lbl500906757)

Label for Tizanidine 4 mg oral tablets by A-S Medication Solutions. The label indicates each tablet contains 4.56 mg tizanidine hydrochloride equivalent to 4 mg tizanidine base. The package contains 90 tablets, with storage instructions to keep at 77 degrees Fahrenheit. It also includes lot and product numbers, a QR code, and the labeler's location in Libertyville, Illinois.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Tizanidine hydrochloride showing its molecular framework including fused rings and attached functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.